About Us

Sarepta Therapeutics Inc. Not Giving Back Gains

By: via Benzinga
Announced additional cinical efficacy and safey data for Eteplirsen. Used for treatment of Duchenne Muscular ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.